BB, you keep posting your predictions. After last month's revenue announcement, I will no longer doubt you. You and Cosmo can predict away as far as I am concerned. Based on my DD, I was told a compounding pharmacy doing $5M per month is considered a successful pharmacy. Mr. Schneiderman has produced a definite winner here. Add the potential of RepiMeds to this financial equation, PIMD, and the other revenue streams and we'll have a company with a $100M annual run rate in no time. Is SCRC really a penny stock? What we have here is one incredible company!